切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Hck - Insulin and Insulin-like Receptors - Ca2 /calmodulin-dependent protein kinases (CaMKs)

15件产品中的 1-10

页面
每页
清除全部
  1. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM激酶II抑制剂
      ≥29.95 mg/mL
      ≥20.7 mg/mL
  2. Rottlerin
    B6803 Rottlerin
     1 Citation
    中文名: 揪毒素
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC抑制剂
      ≥23.6 mg/mL
      insoluble in H2O
  3. Autocamtide-2-related inhibitory peptide
    B6831 Autocamtide-2-related inhibitory peptide
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: 钙调蛋白依赖性蛋白激酶II(CaM激酶II,CaMKII)抑制剂
      ≥40.2 mg/mL
      ≥45.7 mg/mL
  4. KN-93 hydrochloride
    B1306 KN-93 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaMK II抑制剂
      ≥26.9 mg/mL
      ≥5.51 mg/mL
  5. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src抑制剂
      ≥16.55 mg/mL
      insoluble in H2O
  6. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  7. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  8. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  9. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  10. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O

15件产品中的 1-10

页面
每页